- Report
- October 2025
- 217 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 468 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 291 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 476 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 172 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 242 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 174 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 475 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 178 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 475 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 244 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 580 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 208 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 278 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 138 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 480 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 173 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 222 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 205 Pages
Global
From €5189EUR$5,850USD£4,505GBP
- Report
- October 2025
- 465 Pages
Global
From €5189EUR$5,850USD£4,505GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more